Winton Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,189
| Closed | -$41.2K | – | 932 |
|
|
2023
Q1 | $41.2K | Sell |
4,189
-255
| -6% | -$2.51K | ﹤0.01% | 935 |
|
|
2022
Q4 | $83.2K | Buy |
4,444
+300
| +7% | +$5.62K | 0.01% | 887 |
|
|
2022
Q3 | $86K | Sell |
4,144
-382
| -8% | -$7.93K | 0.01% | 899 |
|
|
2022
Q2 | $94K | Buy |
4,526
+1,096
| +32% | +$22.8K | 0.01% | 923 |
|
|
2022
Q1 | $148K | Buy |
3,430
+799
| +30% | +$34.5K | 0.01% | 924 |
|
|
2021
Q4 | $158K | Buy |
2,631
+294
| +13% | +$17.7K | 0.01% | 955 |
|
|
2021
Q3 | $201K | Buy |
2,337
+297
| +15% | +$25.5K | 0.01% | 1242 |
|
|
2021
Q2 | $227K | Buy |
2,040
+436
| +27% | +$48.5K | 0.01% | 1299 |
|
|
2021
Q1 | $179K | Buy |
1,604
+43
| +3% | +$4.8K | 0.01% | 1298 |
|
|
2020
Q4 | $166K | Sell |
1,561
-2,184
| -58% | -$232K | 0.01% | 1217 |
|
|
2020
Q3 | $521K | Sell |
3,745
-11,214
| -75% | -$1.56M | 0.02% | 1101 |
|
|
2020
Q2 | $4.84M | Buy |
+14,959
| New | +$4.84M | 0.12% | 222 |
|